Loading...
Trademark Dashboard – UK Trademark Search & ClearanceUK Trademark — IPO
ELVANSE VUXEN
Application UK00912468898 · Registered
Quick Facts
| Application Number | UK00912468898 |
| Status | Registered |
| Owner | Takeda Pharmaceuticals International AG |
| Filed | 2013-12-27 |
| Registered | 2014-05-08 |
| Renewal Due | 2033-12-27 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. ELVANSE VUXEN is currently a registered UK trademark, with renewal due on 2033-12-27. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Pharmaceutical preparations; pharmaceutical preparations for the treatment of disorders of the central nervous system.
Timeline
- Filed: 2013-12-27
- Registered: 2014-05-08
- Renewal due: 2033-12-27
About This Trademark
'ELVANSE VUXEN' is a registered trademark on the UK IPO register, owned by Takeda Pharmaceuticals International AG. The application (UK00912468898) was filed on 27 December 2013 and registered on 8 May 2014. The registration is set to expire on 27 December 2033.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Potter Clarkson LLP.
Frequently Asked Questions
Who owns UK trademark UK00912468898 ('ELVANSE VUXEN')?
UK trademark UK00912468898 for the mark 'ELVANSE VUXEN' in Class 5 is recorded on the UK IPO register as owned by Takeda Pharmaceuticals International AG. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00912468898 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00912468898 for the mark 'ELVANSE VUXEN' as registered.
Which goods or services does UK trademark UK00912468898 cover?
UK trademark UK00912468898 for the mark 'ELVANSE VUXEN' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations; pharmaceutical preparations for the treatment of disorders of the central nervous system.
When was UK trademark UK00912468898 filed?
UK trademark UK00912468898 for the mark 'ELVANSE VUXEN' was filed at the UK IPO on 27 December 2013 and registered on 8 May 2014.
When does UK trademark UK00912468898 need to be renewed?
UK trademark UK00912468898 for the mark 'ELVANSE VUXEN' is currently recorded as valid until 27 December 2033, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00912468898?
Potter Clarkson LLP is listed as the attorney / representative of record for UK trademark UK00912468898 for the mark 'ELVANSE VUXEN' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.